The propofol infusion 'syndrome' in intensive care unit: From pathophysiology to prophylaxis and treatment

Acta Anaesthesiologica Belgica

Volumn 59, Issue 2, 2008, Pages 79-86

  Papaioannou, V ^b,c   Dragoumanis, C ^c   Theodorou, V ^c   Pneumatikos, I ^a,b,c  

^a Intensive Care Unit

^b Department of Critical Care Medicine ^*  (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Anesthesia; Catecholamines; Critical care; Propofol, rhabdomyolysis

Indexed keywords

LORAZEPAM; MIDAZOLAM; PROPOFOL;

CARDIOVASCULAR DISEASE; CRITICALLY ILL PATIENT; ENERGY YIELD; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPOXIA; INTENSIVE CARE UNIT; LACTIC ACIDOSIS; LIPID METABOLISM; METABOLIC ACIDOSIS; OXIDATIVE PHOSPHORYLATION; PROPOFOL INFUSION SYNDROME; REVIEW; RHABDOMYOLYSIS; SEDATION;

ACIDOSIS; ADULT; ANESTHETICS, INTRAVENOUS; CARDIOVASCULAR DISEASES; CHILD; HEART; HUMANS; HYPERKALEMIA; INTENSIVE CARE UNITS; LIPID METABOLISM; MUSCLE, SKELETAL; PROPOFOL; RHABDOMYOLYSIS; SYNDROME;

EID: 46949107349     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Ahlen K., Buckley C. J., Goodale D. B., et al., The 'propofol infusion syndrome': the facts, their interpretation and implications for patient care, EUR. J. ANAESTHESIOL., 23, 990-8, 2006.
2. Antzelevitch C., Brugada P., Brugada J., et al., Brugada syndrome : 1992-2002 : a historical perspective, J. AM. COLL. CARDIOL., 41, 1665-71, 2003.
3. Augoustides J. G., Culp K. E., Ochroch A. E., et al., Total suppression of cerebral activity by thiopental mimicking propofol infusion syndrome : a fatal common pathway ?, ANESTH. ANALG., 100, 1865, 2005.
4. Barclay K., Williams A. J., Major E., Propofol infusion in children, BRIT. MED. J., 305, 953, 1992.
5. Baumeister F. A., Oberhoffer R., Liebhaber G. M., et al., Fatal propofol infusion syndrome in association with ketogenic diet, NEUROPEDIATRICS, 35, 250-2, 2004.
6. Bodd E., Endresen L., Use of propofol (Diprivan) for children, TIDSSKR. NOR LAEGEFOREN, 112, 1636-7, 1992.
7. Bodor G. S., Porterfield D., Voss E., et al., Cardiac troponin I is not expressed in fetal and adult human skeletal muscle tissue, CLIN. CHEM., 41, 1710-5, 1995.
8. Bray R. J., Fatal myocardial failure associated with a propofol infusion in a child, ANAESTHESIA, 50, 94, 1995.
9. Bray R. J., Propofol infusion syndrome in children, PAEDIATR. ANAESTH., 8, 491-9, 1998.
10. Burow B. K., Johnson M. E., Parker D. L., Metabolic acidosis associated with propofol in the absence of other causative factors, ANESTHESIOLOGY, 101, 239-41, 2004.
11. Cannon M., Glazier S. S., Bauman L. A., Metabolic acidosis, rhabdomyolysis and cardiovascular collapse after prolonged propofol infusion, J. NZEUROSURG., 95, 1053-6, 2001.
12. Casserly B., O'Mahony E., Timm E. G., et al., Propofol infusion syndrome : an unusual cause of renal failure, AM. J. KIDNEY DIS., 44, 98-101, 2004.
13. Cebelin M., Hirsch C. S., Human stress cardiomyopathy, HUM. PATHOL., 11, 123-32, 1980.
14. Cray S. H., Robinson B. H., Cox P. N., Lactic academia and bradyarrhythmia in a child sedated with propofol, CRIT. CARE MED., 26, 2087-92, 1998.
15. Cremer O. L., Moons K. G. M., Bouman E. A. C., et al., Long-term propofol infusion and cardiac failure in adult head-injured patients, LANCET, 357, 117-8, 2001.
16. Crozier T. A., The 'propofol infusion syndrome': myth or menace (Editorial), EUR. J. ANAESTHESIOL., 23, 987-9, 2006.
17. Deschauer M., Mitochondriale Enzephalopathien, PSYCHONEURO, 29, 108-12, 2003.
18. Dixit S., Castlwe M., Velu R. P., et al., Cardiac involvement in patients with acute neurological disease. Confirmation with cardiac troponin I, ARCH. INTERN. MED., 160, 3153-8, 2000.
19. Douglass J. A., Tuxen D. V., Horne M., et al., Myopathy in severe asthma, AM. REV. RESPIR. DIS., 146, 517-9, 1992.
20. Dumaine R., Towbin J. A., Brugada P., et al., Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent, CIRC. RES., 85, 803-9, 1999.
21. Eriksen J., Povey H. M., A case of suspected nonneurosurgical adult fatal propofol infusion syndrome, ACTA ANAESTHESIOL. SCAND., 50, 117-9, 2006.
22. Ernest D., French C., Propofol infusion syndrome-report of an adult fatality, ANAESTH. INTENS. CARE, 31, 316-9, 2003.
23. Folton B., Sorkin E., Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation, DRUGS, 5, 636-57, 1995.
24. Friedman J. A., Manno E., Fulgham J. R., Propofol, J. NEUROSURG., 96, 1161-2, 2002.
25. Fudickar A., Bein B., Tonner P. H., Propofol infusion syndrome in anaesthesia and intensive care medicine, CURR. OPIN. ANAESTHESIOL., 19, 404-10, 2006.
26. Gabow P. A., Kaehny W. D., Kelleher S. P., The spectrum of rhabdomyolysis, MEDICINE, 61, 141-52, 1982.
27. Hanna J. P., Ramundo M. L., Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children, NEUROLOGY, 50, 301-3, 1998.
28. Hill A. B., The environment and disease: association or causation ?, PROC. R. SOC. MED., 58, 295-300, 1965.
29. Holzki J., Aring G., Gillor A., Death after re-exposure to propofol in a 3-year-old child : a case report, PEADIATR. ANAESTH., 14, 265-70, 2004.
30. Hund E., Myopathy in critically ill patients, CRIT. CARE MED., 27, 2544-7, 1999.
31. Iwata M., Zager R. A., Myoglobin inhibits proliferation of cultured human proximal tubular (HK-2) cells, KIDNEY INT., 50, 796-804, 1996.
32. Jouven X., Charles M. A., Desnos M., et al., Circulating non-esterified fatty acid level as a predictive risk factor for sudden death in the population, CIRCULATION, 104, 756-61, 2001.
33. Karch S. B., Billingham M. E., Myocardial contraction band revisited, HUM. PATHOL., 17, 9-13, 1986.
34. Kelly DF, Propofol infusion syndrome, J. NEUROSURG., 95, 925-6, 2001.
35. Knibbe C. A. J., Zuideveld K. P., Dejongh J., et al., Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients : a comparison between propofol 6% and propofol 1%, CLIN. PHARMACOL. THERAP., 72 (6), 670-84, 2002.
36. Kress J. P., O'Connor M. F., Pohlman A. S., et al., Sedation of critically ill patients during mechanical ventilation : a comparison of propofol and midazolam, AM. J. RESP. CRIT. CARE MED., 153, 1012-8, 1996.
37. Liolios A., Guerit J. M., Scholtes J. L., et al., Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult, ANESTH. ANALG., 100, 1804-06, 2005.
38. Marinella M. A., Lactic acidosis associated with propofol, CHEST, 109, 292, 1996.
39. Metha N., DeMunter C., Habibi P., et al., Short-term propofol infusions in children, LANCET, 354, 866-7, 1999.
40. Miner J. R., Burton J. H., Clinical practice advisory : Emergency department procedural sedation with propofol, ANNALS OF EMERGENCY MEDICINE, 50 (2), 182-7, 2007.
41. Motsch J., Roggenbach J., Propofol infusion syndrome, ANAESTHETIST., 53, 1009-22, 2004.
42. Myburgh J. A., Upton R. N., Grant C, et al., Epinephrine, norepinephrine and dopamine infusions decrease propofol concentrations during continuous propofol infusion in an ovine model, INTENSIVE CARE MED., 27, 276-82, 2001.
43. Park T. J., Stevens J. E., Rice A. S. C, et al., Metabolic acidosis and fatal myocardial failure after propofol infusion in children : five case reports, BR. MED. J., 305, 613-6, 1992.
44. Perrier N. D., Baerga-Varela Y., Murray M. J., Death related to propofol use in an adult patient, CRIT. CARE MED., 28, 3071-4, 2000.
45. Plotz F. B., Waalkens H. J., Verkade H. J., et al., Fatal side effects of continuous propofol infusion in children may be related to malignant hyperthermia, ANAESTH. INTENS. CARE, 24, 724, 1996.
46. Priori S. G., Corr P. B., The importance of adrenergic stimulation of cardiac tissue and its contribution to arrhythmogenesis during ischemia, J. CARDIOVASC. ELECTRO-PHYSIOL., 1, 529-42, 1990.
47. Rigoulet M., Devin A., Averet N., et al., Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol, EUR. J. BIOCHEM., 241, 280-5, 1996.
48. Rona G., Catecholamine cardiotoxicity, J. MOLL. CELL. CARDIOL., 17, 291-306, 1985.
49. Salengros J. C., Velghe-Lenelle C. E., Bollens R., et al., Lactic acidosis during propofol-remifentanil anesthesia in an adult, ANESTHESIOLOGY, 101, 241-43, 2004.
50. Schenkman K. A., Yan S., Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy, CRIT. CARE MED., 28, 172-7, 2000.
51. Scutari G., Branca D., Florian M., et al., Mitochondrial studies with a new anaesthetic 2,6-diisopropylphenol, AGRESSOLOGIE, 27, 831-3, 1986.
52. Slater M. S., Mullins R. J., Rhabdomyolysis and myoglobinuria renal failure in trauma and surgical patients : a review, J. AM. COLL. SURG., 186, 693-716, 1998.
53. Stelow E. B., Johari V. P., Smith S. A., et al., Propofol-associated rhabdomyolysis with cardiac involvement in adults : chemical and anatomic findings, CLIN. CHEM., 46, 577-81,2000.
54. Stickland R., Murray M. J., Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit : is there a relationship ?, CRIT. CARE MED., 23, 405-9, 1995.
55. Task Force of the American College of Critical Care Medicine and the Society of Critical Care Medicine, Clinical Practice Guidelines for the sustained use of sedatives and analgesics in the critically ill adult, CRIT. CARE MED., 30, 119-41,2002.
56. Tse H.-F., Yeung C.-K., From profound hypokalaemia to fatal rhabdomyolysis after severe head injury, AM. J. MED., 109, 599-600, 2000.
57. Van Straaten E. A., Hendriks J. J., Ramsey G., et al., Rhabdomyolysis and pulmonary hypertension in a child, possibly due to long-term high-dose propofol infusion, INTENSIVE CARE MED., 22, 997, 1996.
58. Vasile B., Rasulo F., Candiani A., et al., The pathophysiology of propofol infusion syndrome : a simple name for a complex syndrome, INTENSIVE CARE MED., 29, 1417-25, 2003.
59. Vernooy K., Delhaas T., Cremer O. L., et al. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome, HEART RHYTHM, 3, 131-7, 2006.
60. Ksare larger in right than left canine ventricular midmyocardium, CIRCULATION, 99, 206-10, 1999.
61. Walsh R. J., Amato A. A., Toxic myopathies, NEUROL. CLIN., 23, 397-428, 2005.
62. Williams T., O'Hehir R. E., Czarny D., et al., Acute myopathy in sever asthma treated with intravenously administered corticosteroids, AM. REV. RESPIR. DIS., 137, 460-3, 1988.
63. Withington D. E., Decell M. K., Al Ayed T., A case of propofol toxicity : further evidence for a causal mechanism, PEADIATR. ANAESTH., 14, 505-8, 2004.
64. Wolf A. R., Potter F., Propofol infusion in children : when does an anesthetic tool become an intensive care liability ?, PEADIATR. ANAESTH., 14, 435-38, 2004.
65. Wu A. H., Increased troponin in patients with sepsis and septic shock : myocardial necrosis or irreversible myocardial depression ?, INTENSIVE CARE MED., 27, 959-61, 2001.
66. Zager R. A., Myoglobin depletes renal adenine nucleotide pools in the presence and absence of shock, KIDNEY INT., 39, 111-9, 1991.
67. Zeneca Pharmaceuticals, Diprivan professional information brochure, Wilmington DE : Zeneca Pharmaceuticals, 1996.
68. Zhou W., Fortenot H. J., Liu S., et al., Modulation of cardiac calcium channels by propofol, ANESTHESIOLOGY, 86, 670-5, 1997.
69. Zhou W., Fortenot H. J., Wang S. N., et al, Propofol-induced alterations in myocardial beta-adrenoceptor binding and responsiveness, ANESTH. ANALG., 89, 604-8, 1999.